
Dr. Dita Gratzinger, MD, PHD
Pleasanton, CA
16 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Gratzinger, Anatomic Pathologist & Clinical Pathologist in Pleasanton, CA?
Dr. Dita Gratzinger, MD, PHD is an Anatomic Pathologist & Clinical Pathologist, who primarily practices in Pleasanton, CA with 2 additional practice locations. She has been practicing for over 16 years and is board certified. Dr. Gratzinger is fluent in English, Czech, French, and Spanish, and is currently seeing new patients. Dr. Gratzinger’s practice accepts Kaiser Permanente, Medicaid, Medicare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Gratzinger’s office at (650) 498-7103.
Is Dr. Gratzinger board certified as an Anatomic Pathologist & Clinical Pathologist?
Yes, Dr. Dita Gratzinger, MD, PHD is board certified by the American Board of Pathology
What languages does Dr. Gratzinger speak?
Dr. Gratzinger and their clinical team can communicate with patients in the following languages:
Czech
English
French
Spanish
What conditions does an Anatomic Pathologist & Clinical Pathologist like Dr. Gratzinger typically treat?
As an Anatomic Pathologist & Clinical Pathologist, Dr. Gratzinger diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Gratzinger. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Chronic Lymphocytic Leukemia
- Acute Lymphocytic Leukemia
- Chronic Lymphocytic Leukemia Treatment (PDQ®)
- ALL
- Acute lymphocytic leukemia
- Lymphoblastic leukemia
- AML Leukemia
- Acute Myeloblastic Leukemia
- Acute Myelogenous Leukemia
- CLL
- B-cell chronic lymphocytic leukemia
- Lymphocytic leukemia
ICD-10 Codes:
- C9100: Acute lymphoblastic leukemia not having achieved remission
- C9200: Acute myeloblastic leukemia, not having achieved remission
- C9110: Chronic lymphocytic leukemia of B-cell type not having achieved remission
Also known as:
- Multiple Myeloma
- Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)
- Active multiple myeloma
- Untreated multiple myeloma
- Plasma cell myeloma
ICD-10 Codes:
- C9000: Multiple myeloma not having achieved remission
Also known as:
- Localized Swollen Lymph Nodes
- Enlarged glands in one area
- Local lymphadenopathy
- Swollen glands
ICD-10 Codes:
- R590: Localized enlarged lymph nodes
Also known as:
- Anemia
- Low Red Blood Cell Count
- Low Hemoglobin
- Iron deficiency
ICD-10 Codes:
- D649: Anemia, unspecified
Also known as:
- Thrombocytopenia
- Platelet Disorder
- Low platelet count
- Platelet deficiency
- Bleeding disorder
ICD-10 Codes:
- D696: Thrombocytopenia, unspecified
What procedures does an Anatomic Pathologist & Clinical Pathologist like Dr. Gratzinger typically perform?
As an Anatomic Pathologist & Clinical Pathologist, procedures performed by Dr. Dita Gratzinger may include:
- Ancillary Testing
- Blood Sample
- Blood Smear
- Blood Sugar / Plasma Glucose Test
- Bone Pathology
- Chemical Pathology Consultation
- Chemical Pathology Follow Up
- Electrolyte Test / PH Imbalance
Please contact Dr. Gratzinger's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Gratzinger accept my insurance?
Dr. Gratzinger accepts most major insurance plans. Important: Please call our office at (650) 498-7103 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Gratzinger accept in Pleasanton, CA?
Dr. Gratzinger in Pleasanton, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
Blue Shield of California
CVS Health (formerly Aetna)
Kaiser Permanente
Medicaid
Medicare
Santa Cruz County
State of California
UnitedHealth Group
Unknown
View All Insurances
Where is Dr. Gratzinger's office located?
Dr. Dita Gratzinger's Primary Practice
5555 W Las Positas Blvd
Pleasanton, CA 94588
(650) 498-7103
Recognitions
Publications
Vascular endothelial growth factor: the salt in the Hodgkin cytokine stew?
, 2014
Intravascular ALK-negative Aplastic Large Cell Lymphoma With Localized Cutaneous Involvement
, 2013
Update on Myelodysplastic Syndromes Classification and Prognosis
, 2013
IgG4-positive Sclerosing Orbital Inflammation Involving the Conjunctiva: A Case Report
, 2012
Histoplasmosis Presenting with Ulcers on the Soft Palate
, 2012
Distinctive contact between CD34+ hematopoietic progenitors
, 2012
In situ vaccition against mycosis fungoides by intratumoral injection of a TLR9 agonist combined
, 2012
In Situ Vaccition with TLR9 Agonist Combined with Local Radiation In Mycosis Fungoides
, 2010
CD81 protein is expressed at high levels in normal germil center B cells
, 2010
Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival
, 2010
Prognostic significance of vascular endothelial growth factor (VEGF), VEGF receptors (VEGFR)
The Transcription Factor LMO2 Is a Robust Marker of Vascular Endothelium and Vascular Neoplasms
, 2009
CD81 Protein Is Expressed in Normal Germil Center B-Cells
, 2009
VEGF-C: putting the 'lymph' back in lymphoma?
, 2009
Lymphoma-Expressed VEGF-a,VEGFR-1
, 2008
Neither CD68+Nor CD163+Macrophages Are Associated with Decreased Survival in Follicular Lymphoma
, 2008
The transcription factor LMO2 is a robust marker of vascular endothelium
Ameloblastoma, calcifying epithelial odontogenic tumor
, 2008
LMO2 protein expression predicts survival in patients with diffuse large B
, 2008
LMO2 protein expression predicts survival in patients with diffuse large B
, 2008
Prognostic significance of VEGF, VEGF receptors
, 2008
Microvessel density and expression of vascular endothelial growth factor and its receptors
, 2007
Identification of the regions of PECAM-1 involved in beta- and gamma-catenin associations
, 2005
Platelet endothelial cell adhesion molecule
, 2003
Elevated glucose inhibits VEGF-A-mediated endocardial cushion formation
, 2003
Platelet-endothelial cell adhesion molecule
, 2003
Interpreting a medium-resolution model of tubulin
, 1996